Lipikind 20 Tablet contains Atorvastatin 20mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the management of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Atorvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby decreasing cholesterol production in the liver and enhancing clearance of LDL particles from the bloodstream. This therapeutic effect contributes to the prevention of atherosclerotic cardiovascular disease, including myocardial infarction, stroke, and angina. Lipikind 20 is prescribed as part of a comprehensive treatment plan that includes diet modification, exercise, and weight control. It is suitable for patients with primary hyperlipidemia, familial hypercholesterolemia, and those at high risk for cardiovascular events. The recommended dosage should be individualized based on patient response and lipid profile monitoring. Common adverse effects may include headache, myalgia, and gastrointestinal disturbances. Liver function tests and creatine kinase levels should be periodically assessed to monitor for potential hepatotoxicity and myopathy. Lipikind 20 should be used with caution in patients with hepatic impairment and contraindicated during pregnancy and lactation.